等待开盘 06-15 09:30:00 美东时间
-0.090
-0.26%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Oppenheimer analyst Ian Zaffino maintains Consensus Cloud Solns (NASDAQ:CCSI) with a Outperform and raises the price target from $32 to $35.
05-13 01:37
US stocks, including Monster Beverage Corp, rose on Friday. Monster Beverage reported better-than-expected financial results, causing a 12.8% jump in their shares.
05-08 22:15
Consensus Cloud Solns (NASDAQ:CCSI) is looking for Q2 Adj EPS of $1.43-$1.53 vs $1.44 analyst estimate. sees sales of $87.900 million-$91.900 million vs $89.239 million analyst estimate.
05-08 04:04
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从12.5美元升至13美元;Lake Street:维持Insight Molecular"买入"评级,目标价从8美元升至12美元
02-18 16:48
Shares of software companies are trading higher after JPMorgan strategists sugg...
02-11 02:32
Consensus Cloud Solutions (NASDAQ:CCSI) reported quarterly earnings of $1.41 per share which beat the analyst consensus estimate of $1.38 by 2.4 percent. This is a 6.82 percent increase over earnings of $1.32 per share
02-10 16:33
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
Wedbush analyst Daniel Ives maintains Consensus Cloud Solns (NASDAQ:CCSI) with a Outperform and raises the price target from $26 to $35.
2025-11-06 21:49
Consensus Cloud Solutions (NASDAQ:CCSI) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.36 by 1.69 percent. This is unchanged from the same period last year. The company
2025-11-06 06:54